Large-dose infusions of heparinoid ORG 10172 in ischemic stroke

E. W. Massey, J. Biller, J. N. Davis, H. P. Adams, J. R. Marler, L. B. Goldstein, M. Alberts, A. Bruno

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

We evaluated the safety and possible efficacy of large doses of the heparinoid ORG 10172 in 57 patients with acute or progressing ischemic stroke. Patients received a loading bolus of the drug followed by a maintenance intravenous infusion for 7 days. The plasma level of ORG 10172 was monitored by the degree of inhibition of coagulation factor Xa. In general, the drug was well tolerated and few hemorrhagic complications occurred. Two patients with large cardioembolic hemispheric strokes had intracranial hemorrhagic complications. Most patients improved during treatment. By 3 months after the stroke, 37 patients (65%) had a favorable outcome (minimal or no residual disability). This study suggests that high-dose intravenous infusions of ORG 10172 can be safely given to patients with acute ischemic stroke.

Original languageEnglish (US)
Pages (from-to)1289-1292
Number of pages4
JournalStroke
Volume21
Issue number9
StatePublished - Sep 1990

Fingerprint

Heparinoids
Stroke
Intravenous Infusions
Blood Coagulation Factors
Pharmaceutical Preparations
Maintenance
Safety

Keywords

  • Anticoagulants
  • Cerebral ischemia
  • Early treatment

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Neuroscience(all)

Cite this

Massey, E. W., Biller, J., Davis, J. N., Adams, H. P., Marler, J. R., Goldstein, L. B., ... Bruno, A. (1990). Large-dose infusions of heparinoid ORG 10172 in ischemic stroke. Stroke, 21(9), 1289-1292.

Large-dose infusions of heparinoid ORG 10172 in ischemic stroke. / Massey, E. W.; Biller, J.; Davis, J. N.; Adams, H. P.; Marler, J. R.; Goldstein, L. B.; Alberts, M.; Bruno, A.

In: Stroke, Vol. 21, No. 9, 09.1990, p. 1289-1292.

Research output: Contribution to journalArticle

Massey, EW, Biller, J, Davis, JN, Adams, HP, Marler, JR, Goldstein, LB, Alberts, M & Bruno, A 1990, 'Large-dose infusions of heparinoid ORG 10172 in ischemic stroke', Stroke, vol. 21, no. 9, pp. 1289-1292.
Massey EW, Biller J, Davis JN, Adams HP, Marler JR, Goldstein LB et al. Large-dose infusions of heparinoid ORG 10172 in ischemic stroke. Stroke. 1990 Sep;21(9):1289-1292.
Massey, E. W. ; Biller, J. ; Davis, J. N. ; Adams, H. P. ; Marler, J. R. ; Goldstein, L. B. ; Alberts, M. ; Bruno, A. / Large-dose infusions of heparinoid ORG 10172 in ischemic stroke. In: Stroke. 1990 ; Vol. 21, No. 9. pp. 1289-1292.
@article{86462b76cdce4e2aa123fe9695577914,
title = "Large-dose infusions of heparinoid ORG 10172 in ischemic stroke",
abstract = "We evaluated the safety and possible efficacy of large doses of the heparinoid ORG 10172 in 57 patients with acute or progressing ischemic stroke. Patients received a loading bolus of the drug followed by a maintenance intravenous infusion for 7 days. The plasma level of ORG 10172 was monitored by the degree of inhibition of coagulation factor Xa. In general, the drug was well tolerated and few hemorrhagic complications occurred. Two patients with large cardioembolic hemispheric strokes had intracranial hemorrhagic complications. Most patients improved during treatment. By 3 months after the stroke, 37 patients (65{\%}) had a favorable outcome (minimal or no residual disability). This study suggests that high-dose intravenous infusions of ORG 10172 can be safely given to patients with acute ischemic stroke.",
keywords = "Anticoagulants, Cerebral ischemia, Early treatment",
author = "Massey, {E. W.} and J. Biller and Davis, {J. N.} and Adams, {H. P.} and Marler, {J. R.} and Goldstein, {L. B.} and M. Alberts and A. Bruno",
year = "1990",
month = "9",
language = "English (US)",
volume = "21",
pages = "1289--1292",
journal = "Stroke",
issn = "0039-2499",
publisher = "Lippincott Williams and Wilkins",
number = "9",

}

TY - JOUR

T1 - Large-dose infusions of heparinoid ORG 10172 in ischemic stroke

AU - Massey, E. W.

AU - Biller, J.

AU - Davis, J. N.

AU - Adams, H. P.

AU - Marler, J. R.

AU - Goldstein, L. B.

AU - Alberts, M.

AU - Bruno, A.

PY - 1990/9

Y1 - 1990/9

N2 - We evaluated the safety and possible efficacy of large doses of the heparinoid ORG 10172 in 57 patients with acute or progressing ischemic stroke. Patients received a loading bolus of the drug followed by a maintenance intravenous infusion for 7 days. The plasma level of ORG 10172 was monitored by the degree of inhibition of coagulation factor Xa. In general, the drug was well tolerated and few hemorrhagic complications occurred. Two patients with large cardioembolic hemispheric strokes had intracranial hemorrhagic complications. Most patients improved during treatment. By 3 months after the stroke, 37 patients (65%) had a favorable outcome (minimal or no residual disability). This study suggests that high-dose intravenous infusions of ORG 10172 can be safely given to patients with acute ischemic stroke.

AB - We evaluated the safety and possible efficacy of large doses of the heparinoid ORG 10172 in 57 patients with acute or progressing ischemic stroke. Patients received a loading bolus of the drug followed by a maintenance intravenous infusion for 7 days. The plasma level of ORG 10172 was monitored by the degree of inhibition of coagulation factor Xa. In general, the drug was well tolerated and few hemorrhagic complications occurred. Two patients with large cardioembolic hemispheric strokes had intracranial hemorrhagic complications. Most patients improved during treatment. By 3 months after the stroke, 37 patients (65%) had a favorable outcome (minimal or no residual disability). This study suggests that high-dose intravenous infusions of ORG 10172 can be safely given to patients with acute ischemic stroke.

KW - Anticoagulants

KW - Cerebral ischemia

KW - Early treatment

UR - http://www.scopus.com/inward/record.url?scp=0025183006&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025183006&partnerID=8YFLogxK

M3 - Article

C2 - 2396265

AN - SCOPUS:0025183006

VL - 21

SP - 1289

EP - 1292

JO - Stroke

JF - Stroke

SN - 0039-2499

IS - 9

ER -